COVID-19 mRNA vaccines enhance cancer treatment and survival
Originally Published 2 months ago — by ScienceDaily
New research suggests that COVID-19 mRNA vaccines may boost survival rates in patients with advanced lung and skin cancers when administered within 100 days of starting immunotherapy, potentially paving the way for a universal cancer vaccine. The findings, based on patient data and mouse experiments, are preliminary but promising, prompting plans for further clinical trials.